A total of 104 elderly patients were immunized with one or two doses of the commercial 1985-1986 inactivated influenza vaccine formulation. Two types of vaccines (split virus [SV] vaccine and whole virus [WV] vaccine) and one or two doses 1 month apart were given. No difference in local or systemic reactions was noted among the four groups. The reciprocal geometric mean hemagglutination inhibition antibody titers against influenza A/Philippines/82 (H3N2) after one or two doses were: 78 for SV vaccine (one dose), 65 for SV vaccine (two doses), 55 for WV vaccine (one dose), and 51 for WV vaccine (two doses). Similar nonsignificant differences were observed for the other two antigens contained in the vaccine. The percentage with a hemagglutination inhibition titer of .1:40 also did not differ after one or two doses. We then compared the postvaccination hemagglutination inhibition titers in young and old patients from previous studies in which apparent differences had appeared. We retested all sera simultaneously on the same day with the same reagents. No significant differences were apparent among age groups. In summary, the humoral immune response to inactivated influenza vaccine in healthy ambulatory elderly patients who have been previously immunized may not differ significantly from that of children and young adults. A booster dose 1 month after the first dose does not enhance immune responses in the elderly.
The equality of the immune response to influenza vaccine in young and old adults is still a subject of debate. Several studies indicate significant differences in responses (5, 6, 10) . Others show no difference (1, 12) . The discrepancy among these findings may be caused by differences in the health status of the elderly adults, or there may be a subgroup of the elderly who respond poorly to immunization although the rest respond in a satisfactory way (13) .
We have been studying different methods for improving the immune responses to influenza vaccine. First, we administered two to three times the standard vaccine dose. AIthough the higher doses were well tolerated, the immune response improved only slightly (P. A. Gross, M. E. Weksler, and G. V. Quinnan, Jr., Program Abstr. 25th Intersci. Conf. Antimicrob. Agents Chemother., abstr. no. 972, 1985) . Higher multiples of the standard dose will undoubtedly be necessary to significantly improve the immune response (9, 12) . The cost of higher doses may be prohibitive. Alternative approaches need to be examined.
In the present study, we studied whether two standard doses given 1 month apart would enhance the immune response of elderly adults. We reasoned that the second dose might significantly boost the antibody response that was stimulated by the initial dose. In young children, two doses are clearly superior to one dose (8, 14) .
MATERIALS AND METHODS
In the fall of 1985, we immunized 104 elderly persons with standard doses of the commercially licensed influenza vaccine (4 The patients were randomly assigned to one of four groups. Group A received one dose of SV vaccine; group B received two doses of SV vaccine given 1 month apart; group C received one dose of WV vaccine; and group D received two doses of WV vaccine given 1 month apart.
We also compared the immune response in this elderly group with that in a younger group of children and young adults with cystic fibrosis. The younger patients are immunized annually as part of an influenza vaccine study at St. Vincent's Hospital in New York City described previously (9) . The younger patients received one dose of 0.5 ml of the SV vaccine.
Serum hemagglutination inhibition (HI) antibody titers were determined before immunization and 4 weeks after the first and second immunizations by methods described previously (9, 11 First, the elderly patients vaccinated were healthy ambuladifference is significant, the difference in prevaccination tory individuals. The impaired immune response that might titers probably accounts for the difference in postvaccination be overcome with a vaccine booster may be more likely in titers. The prevaccination titer was higher in the group that infirm or bedridden elderly persons or in a small subgroup of exhibited the higher postvaccination titer.
healthy elderly persons (6, 13) . Second, the elderly patients The percentage of subjects with an HI titer equal to or studied had been previously immunized either the previous greater than 1:40 is shown for the same serum pairs in Table  year or the year before that. Consequently, the first immu-2. The titer of 1:40 was selected because this is the level of nizing dose may have maximally stimulated their HI anti-HI antibody that usually protects one from acquiring influbody titers. Prior immunization may have adequately primed enza virus infection (9) . Between 70 and 100% of patients the ability of their humoral immune system to respond to the developed presumably protective antibody titers against ail influenza vaccine strains. Last, the group sizes may have three vaccine strains. No significant differences were obbeen insufficient to detect a small but significant difference.
served among the four vaccine groups. A second dose did Although such an error related to sample size is possible, the not improve the antibody titer that developed after one dose. differences observed were so small that it is unlikely that the 
